Skip to main content
Natco Pharma Ltd. logo

Natco Pharma Ltd. — Investor Relations & Filings

Ticker · NATCOPHARM ISIN · INE987B01026 LEI · 33580086GIBRWXSNGG39 BSE.NS Manufacturing
Filings indexed 1,708 across all filing types
Latest filing 2019-10-01 Regulatory Filings
Country IN India
Listing BSE.NS NATCOPHARM

About Natco Pharma Ltd.

https://www.natcopharma.co.in/

Natco Pharma Ltd. is a vertically integrated organization focused on the development, manufacturing, and marketing of complex generics and active pharmaceutical ingredients (APIs). The company specializes in niche therapeutic areas, maintaining a leadership position in oncology and a significant presence in specialty segments such as hepatology, cardiology, and diabetology. Natco is recognized for its expertise in high-barrier-to-entry products, including complex oral solids and injectables. Its business model emphasizes research and development to deliver affordable versions of life-saving medicines globally. With a robust portfolio of finished dosage formulations and a strong supply chain for APIs, the company serves diverse international markets, including North America, Europe, and emerging economies, through strategic partnerships and direct distribution channels.

Recent filings

Filing Released Lang Actions
NATCO RECEIVES ESTABLISHMENT INSPECTION REPORT FOR MEKAGUDA's ACTIVE PHARMACEUTICAL INGREDIENT FACILITY
Regulatory Filings
2019-10-01 English
Trading Window
Regulatory Filings Classification · 95% confidence The document text is extremely short (59 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report content, or any announcement text. Given the lack of information, the document cannot be classified as a report or detailed filing. It fits best as a Regulatory Filing (RNS) which is the fallback category for miscellaneous or insufficient content filings.
2019-09-30 English
Closing of Trading Window
Regulatory Filings
2019-09-30 English
Allotment of 1,25,215 Equity shares of Rs.2/- each under NATCO Employee Stock Option Scheme(NATSOP2015)
Regulatory Filings
2019-09-28 English
Allotment of ESOP/ESPS
Regulatory Filings
2019-09-28 English
Investor Presentation
Regulatory Filings
2019-09-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.